Skip to content

Aberrant microRNA expression and connectome as biomarkers in diagnosis and prognosis predicton for schizophrenia

Aberrant microRNA expression and connectome as biomarkers in diagnosis and prognosis predicton for schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17014213
Enrollment
Unknown
Registered
2017-12-29
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Schizophrenia Group:None
Prodromal Group:None
Healthy Controls:None

Sponsors

Brain Hospital affiliated with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged between 18 and 45 years old; (2) Three groups will be recruited, patients fulfilled the diagnostic criteria for schizophrenia (DSM-5), individuals identified with clinical high risk(CHR) by the SIPS/SOPS (Structured Interview for Prodromal Symptoms and the Scale of Prodromal Syndromes), healthy controls with a negative family history of mental disorders matched to the other two groups by age, gender, and education; (3) The primary school education degree and above; (4) Subjects (or their guardians) must be signed informed consent, showing that they already understand the research and the purpose of the program and voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: (1) Combined with serious physical disease; (2) Current or past alcohol or substance dependence; (3) With mental retardation; (4) One who is excited, impulsivity, aggression; (5) One who had suicidal behavior or existing suicide attempts; (6) One who underwent modified electroconvulsive therapy or psychological treatment system within 6 months prior to screening; (7) One who had visual, auditory damage and is still unable to complete the test after correction; (8) Other situations not to participate in training or evaluation.

Design outcomes

Primary

MeasureTime frame
MicroRNA expression;Structural and functional magnetic resonance imaging;Rest-state and event-related magnetic fields;SAPS, SANS;HAMD;PANSS;MCCB;

Countries

China

Contacts

Public ContactShiping Xie

Brain Hospital affiliated with Nanjing Medical University

xieshiping@medmail.com.cn+86 13851588810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026